← Leaderboards
Kenneth Patrick Smith
Beth Israel Deaconess Medical Center
$175,422
Attributed
$175,422
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61.2K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$175,422 · 1
By mechanism
F32$175,422 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- James E Kirby$9,890,264
- Thea Brennan-Krohn$2,347,967
- David J Friedman$7,089,711
- Martin R. Pollak$37,233,145
- Robert C Flaumenhaft$19,499,862
Others in their field
Other Emerging Leaders on “Alternative Treatment”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Christopher Barnaby Nelson · University Of Melbourne$26,782,982
- Craig Reist · Research Triangle Institute$22,725,934
- Lisa Newman · Research Triangle Institute$22,725,934
- Gary Fanger · Rise Therapeutics, Llc$9,510,819
Research focus
Alternative TreatmentAntibioticsAnti-Infective AgentsAntibiotic ResistanceAntimicrobial EffectAreaBacteriaBaseAntimicrobialCarbapenemaseCarbapenem ResistanceCarbapenem-Resistant EnterobacteriaceaeCarbapenemsCellular TargetingCell WallCenters For Disease Control And Prevention (U.S.)CollaborationsCollectionConsultationsCounterscreenCrosslinkDoctor Of PhilosophyDoseEffective Therapy
Grant awards (3)
Identification and Characterization of Novel Antimicrobial Adjunctives to Restore Susceptibility to Carbapenem Resistant Enterobacteriaceae$57,182
F32 · FY2019 · AI · contact PI
Identification and Characterization of Novel Antimicrobial Adjunctives to Restore Susceptibility to Carbapenem Resistant Enterobacteriaceae$61,174
F32 · FY2018 · AI · contact PI
Identification and Characterization of Novel Antimicrobial Adjunctives to Restore Susceptibility to Carbapenem Resistant Enterobacteriaceae$57,066
F32 · FY2017 · AI · contact PI